Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy

被引：0
|
作者：
Mariya Asenova Stoynova
Alexander Dimitrov Shinkov
Inna Dimitrova Dimitrova
Inna Angelova Yankova
Roussanka Dimitrova Kovatcheva
机构：
[1] Medical University of Sofia,Department of Endocrinology
[2] University Hospital of Endocrinology,undefined
来源：
International Ophthalmology | 2023年 / 43卷
关键词：
Graves’ orbitopathy; Glucocorticoid regimens; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4747 / 4757
页数：10
相关论文
共 50 条
  • [41] Association between Clinical Activity Score and Serum Interleukin-6, Interleukin-8 and Interleukin-10 during Systemic Glucocorticoid Treatment for Active Moderate-to-Severe Graves' Orbitopathy
    Stoynova, Mariya Asenova
    Shinkov, Alexander Dimitrov
    Georgiev, Georgi Kirilov
    Kovatcheva, Roussanka Dimitrova
    CURRENT EYE RESEARCH, 2021, 46 (10) : 1503 - 1508
  • [42] MabThera use and efficacy in patients with active moderate to severe Graves' Orbitopathy: a multicentre retrospective study of 40 cases
    Lebranchu, P.
    Deltour, J. B.
    Cariou, B.
    Vabres, B.
    D'Assigny, M.
    Drui, D.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [43] Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves' Orbitopathy
    Yu, Yun
    Hu, Yu-xin
    Lu, Ming-xi
    Ouyang, Zheng-long
    Xu, Ming-tong
    Zhao, Li-yan
    Wang, Mei
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (04) : 1015 - 1024
  • [44] Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves' orbitopathy
    Park, Jungyul
    Kim, Jaehyun
    Kim, Sang Soo
    Choi, Hee-Young
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [45] Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy
    Ueda-Sakane, Yoriko
    Kanamoto, Naotetsu
    Fushimi, Yasutaka
    Tanaka-Mizuno, Sachiko
    Yasuno, Shinji
    Miura, Masako
    Sone, Masakatsu
    Yasoda, Akihiro
    Okada, Tomohisa
    Togashi, Kaori
    Nakao, Kazuwa
    Inagaki, Nobuya
    ENDOCRINE JOURNAL, 2016, 63 (08) : 703 - 714
  • [46] Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves’ Orbitopathy
    Yun Yu
    Yu-xin Hu
    Ming-xi Lu
    Zheng-long Ouyang
    Ming-tong Xu
    Li-yan Zhao
    Mei Wang
    Ophthalmology and Therapy, 2024, 13 : 1015 - 1024
  • [47] Efficacy and Safety of Different Intravenous Glucocorticoid Regimens in the Treatment of Graves' Ophthalmopathy: A Meta-Analysis
    Chen, Jing
    Xu, Nuo
    Sun, Huilan
    Chen, Gang
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [48] The use of lymecycline in the treatment of moderate to severe acne vulgaris: a comparison of the efficacy and safety of two dosing regimens
    Dubertret, L
    Alirezai, M
    Rostain, G
    Lahfa, M
    Forsea, D
    Niculae, BD
    Simola, M
    Horvath, A
    Mizzi, F
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (01) : 44 - 48
  • [49] Establishment and Comparison of Two Different Animal Models of Graves' Orbitopathy
    Wang, Wei
    Zhang, Jing-Wen
    Qin, Yu-Jie
    Li, Hong-Yan
    Dai, Yu-Xiang
    Li, Hong
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2023, 12 (06):
  • [50] Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
    Joanna Rymuza
    Michał Popow
    Zuzanna Żurecka
    Jerzy Przedlacki
    Tomasz Bednarczuk
    Piotr Miśkiewicz
    Endocrine, 2019, 64 : 308 - 315
12345